164 followers
RT @cardiomet_CE: 11b) In the COMPASS trial analyses in JACC 2019 - this was clearly shown. 🔓https://t.co/jkypZrZRdp https://t.co/8mwzmJg6ku
RT @cardiomet_CE: 11b) In the COMPASS trial analyses in JACC 2019 - this was clearly shown. 🔓https://t.co/jkypZrZRdp https://t.co/8mwzmJg6ku
11b) In the COMPASS trial analyses in JACC 2019 - this was clearly shown. 🔓https://t.co/jkypZrZRdp https://t.co/8mwzmJg6ku
RT @accpcardprn: #WhatsNewWednesday Do you struggle to identify patients with PAD for dual-pathway inhibition with rivaroxaban and aspiri…
RT @accpcardprn: #WhatsNewWednesday Do you struggle to identify patients with PAD for dual-pathway inhibition with rivaroxaban and aspiri…